申请人:LA JOLLA PHARMACEUTICAL CO.
公开号:EP2283833A2
公开(公告)日:2011-02-16
Compositions and methods are disclosed for inhibiting semicarbazide-sensitive amine oxidase (SSAO), also known as vascular adhesion protein-1 (VAP-1). The compounds disclosed are amine-containing and amide-containing compounds. The compounds and compositions are useful for treatment of diseases, including inflammation, inflammatory diseases and autoimmune disorders.
本发明公开了用于抑制半卡巴肼敏感胺氧化酶(SSAO)(又称血管粘附蛋白-1(VAP-1))的化合物和方法。所公开的化合物是含胺和含酰胺的化合物。这些化合物和组合物可用于治疗疾病,包括炎症、炎性疾病和自身免疫性疾病。